Cytostatic and Apoptotic Effects of Bisphosphonates on Prostate Cancer Cells
- 1 April 2004
- journal article
- Published by Elsevier in European Urology
- Vol. 45 (4) , 521-529
- https://doi.org/10.1016/j.eururo.2003.12.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Nitrogen Containing Bisphosphonates Induce Apoptosis and Inhibit the Mevalonate Pathway, Impairing Ras Membrane Localization in Prostate Cancer CellsJournal of Urology, 2003
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral EnvironmentJournal of Bone and Mineral Research, 1999
- Prenyltransferase Inhibitors Induce Apoptosis in Proliferating Thyroid Cells through a p53-Independent, CrmA-Sensitive, and Caspase-3-Like Protease- Dependent MechanismEndocrinology, 1999
- Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53Oncogene, 1998
- Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.Journal of Clinical Investigation, 1997
- Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.Journal of Clinical Investigation, 1995
- The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2.The Journal of cell biology, 1991
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitroBone, 1987